Letroz Tablets IP 2.5 mg (Letrozole)

Letroz Tablets IP 2.5 mg contain Letrozole IP 2.5 mg, an aromatase inhibitor medicine used for certain hormone-dependent conditions. The appropriate indication, dose and duration should be determined by a qualified specialist.

• Contains Letrozole 2.5 mg
• Aromatase inhibitor medicine
• Film-coated tablet formulation
• Used for certain hormone-dependent conditions
• Manufactured by Sun Pharmaceutical Industries Ltd.
• Prescription medicine for specialist-directed use

• Take Letroz Tablets exactly as prescribed by your treating specialist.
• Swallow the tablet with water.
• Take it at the prescribed time and dose.
• Do not change the dose or discontinue treatment without medical advice.

Active Ingredient: Letrozole IP 2.5 mg
Dosage Form: Film-Coated Tablets
Manufacturer: Sun Pharmaceutical Industries Ltd.
Composition: Letrozole IP 2.5 mg + Excipients q.s.
Colours: Ferric Oxide (Yellow) USP-NF, Titanium Dioxide IP
Category: Aromatase Inhibitor
Prescription Status: Schedule H Prescription Medicine

• Schedule H Prescription Drug – Use only under the supervision of a qualified healthcare professional.
• Inform your doctor about all medicines and supplements you are taking.
• Letrozole may cause side effects and may not be suitable for everyone.
• Store at room temperature.
• Protect from light and moisture.
• Keep out of reach of children.
• Keep tablets in their original packaging until use.
• Do not use after the expiry date.

Letroz Tablets IP 2.5 mg is a prescription medicine. The information provided is for general informational purposes only and does not replace professional medical advice, diagnosis or treatment. Always use this medicine strictly according to the prescription and advice of your treating specialist.